A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX) Meeting Abstract
| Authors: | Atkins, K. M.; Gong, J.; Tighiouart, M.; Klempner, S. J.; Tuli, R.; Placencio-Hickok, V.; Hendifar, A. E. |
| Abstract Title: | A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX) |
| Meeting Title: | 2020 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000530922700752 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.4_suppl.TPS780 |
| Notes: | Meeting Abstract: TPS780 -- Source: Wos |
